RT Journal Article
SR Electronic
T1 A Data-Driven Biopsychosocial Framework Determining the Spreading of Chronic Pain
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.22.22277850
DO 10.1101/2022.07.22.22277850
A1 Tanguay-Sabourin, Christophe
A1 Fillingim, Matt
A1 Parisien, Marc
A1 Guglietti, Gianluca V
A1 Zare, Azin
A1 Norman, Jax
A1 Da-ano, Ronrick
A1 Perez, Jordi
A1 Thompson, Scott J
A1 Martel, Marc O
A1 Roy, Mathieu
A1 Diatchenko, Luda
A1 Vachon-Presseau, Etienne
YR 2022
UL http://medrxiv.org/content/early/2022/07/22/2022.07.22.22277850.abstract
AB Chronic pain conditions are complex syndromes characterized by a mosaic of biological, psychological, and social factors. We derived predictive models for the number of co- existing pain sites in the UK Biobank and identified a common risk score that classified different chronic pain conditions in cross-sectional data, predicted the development of chronic pain in pain-free individuals, and determined the spreading of chronic pain to multiple sites or its recovery nine years later. The features with the strongest prognosis included sleeplessness, feeling ‘fed-up’, tiredness, stressful life events, and a BMI > 30. The risk score for pain was associated with an inflammatory blood marker, a polygenic risk score for pain, and a neuroimaging-based marker for sustained pain. The demonstration of a common biopsychosocial risk factor for different clinical pain conditions may help better characterize a general chronic pain syndrome, tailor research protocols, optimize patient randomization in clinical trials, and improve pain management.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was primarily supported by the Canadian Institutes of Health Research (CIHR), #RN441786 - 45309. This research has been conducted in part using the UK Biobank Resource under Application Number 20802.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants provided written, informed consent, and the study was approved by the North West Multi-centre Research Ethics Committee (REC number 11/NW/0382) to obtain and disseminate data and samples from the participants (http://www.ukbiobank.ac.uk/ethics/), and these ethical regulations cover the work in this study. Written informed consent was obtained from all participants.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are provided from the UK Biobank and available to other investigators online upon permission granted by www.ukbiobank.ac.uk. Restrictions apply to the availability of these data, which were used under license for the current study (Project ID: 20802).